Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 40,374 | 80,001 | 250,008 | 40,907 | 37,415 |
| Gross Profit | 40,374 | 80,001 | 250,008 | 40,907 | 37,415 |
| Operating Expenses | 172,218 | 163,288 | 127,994 | 91,744 | 111,033 |
| Operating Income | -131,844 | -83,287 | 122,014 | -50,837 | -73,618 |
| Other Income | 12,267 | 18,950 | 11,724 | 4,445 | 2,421 |
| Pre-tax Income | -119,577 | -64,337 | 133,738 | -46,392 | -71,197 |
| Income Tax | 144 | 665 | 1,408 | 16 | N/A |
| Net Income Continuous | -119,721 | -65,002 | 132,330 | -46,408 | -71,197 |
| Net Income | $-119,721 | $-65,002 | $132,330 | $-46,408 | $-71,197 |
| EPS Basic Total Ops | -2.04 | -1.13 | 3.08 | -1.21 | -1.89 |
| EPS Basic Continuous Ops | -2.04 | -1.13 | 3.08 | -1.21 | -1.89 |
| EPS Diluted Total Ops | -2.04 | -1.13 | 2.97 | -1.21 | -1.89 |
| EPS Diluted Continuous Ops | -2.04 | -1.13 | 2.97 | -1.21 | -1.89 |
| EPS Diluted Before Non-Recurring Items | -2.04 | -1.13 | 2.97 | -1.21 | -1.89 |
| EBITDA(a) | $-130,757 | $-86,525 | $122,829 | $-44,662 | $-68,104 |